About Kebotix
Kebotix is a company based in Cambridge (United States) founded in 2017 by Dennis Sheberla. Kebotix has raised $23.65 million across 7 funding rounds from investors including U.S. Environmental Protection Agency, Constructor Capital and OSTI.GOV. Kebotix offers products and services including Kebotix AI Platform and Self-Driving Lab. Kebotix operates in a competitive market with competitors including Citrine Informatics, Numat, Enzymit, Molecule.one and Chemical.AI, among others.
- Headquarter Cambridge, United States
- Founders Dennis Sheberla
-
Sectors
Chemicals & MaterialsIndustrial Goods & Manufacturing Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kebotix, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$23.65 M (USD)
in 7 rounds
-
Latest Funding Round
$5 M (USD), Series B
Jul 22, 2024
-
Investors
U.S. Environmental Protection Agency
& 10 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kebotix
Kebotix offers a comprehensive portfolio of products and services, including Kebotix AI Platform and Self-Driving Lab.
Platform for rapid discovery of chemicals and materials using AI.
System combining AI and automation for optimized materials processes.
People of Kebotix
Unlock access to complete
Unlock access to complete
Funding Insights of Kebotix
Kebotix has successfully raised a total of $23.65M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $5 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kebotix
Kebotix has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include U.S. Environmental Protection Agency, Constructor Capital and OSTI.GOV.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund is operated to support early-stage technology startups.
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked | |
|
Venture capital firm focused on multiple sectors
|
Locked | Locked | Locked |
Investor details for Kebotix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kebotix
Investment portfolio details for Kebotix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kebotix
Detailed financials for Kebotix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kebotix Comparisons
Peer comparison for Kebotix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kebotix
Kebotix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Citrine Informatics, Numat, Enzymit, Molecule.one and Chemical.AI, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-based solutions for materials informatics
|
|
| Locked | Locked | Locked |
Provider of chemical packaging, protection & separation services
|
|
| Locked | Locked | Locked |
AI-powered algorithms for enzyme design and optimization are provided.
|
|
| Locked | Locked | Locked |
AI-based software for molecule drug design and synthesis is provided.
|
|
| Locked | Locked | Locked |
Provider of AI-based chemical synthesis and medicinal analysis platform for researchers
|
Detailed competitors of Kebotix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kebotix
Complete news archive for Kebotix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kebotix
Kebotix was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Kebotix is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Jill Becker is the current CEO of Kebotix.
Kebotix is a funded company, having raised a total of $23.65M across 7 funding rounds to date.
AI solutions for materials discovery. Its technology integrates cloud technologies, artificial intelligence, chemical informatics, physical modeling, and lab automation to support the RD process. It accelerate the discovery, testing, and production processes of new molecules.
Kebotix's top competitors include Citrine Informatics, Numat and Enzymit.
Kebotix offers Kebotix AI Platform and Self-Driving Lab.
Kebotix has 11 investors. Key investors include U.S. Environmental Protection Agency, Constructor Capital, OSTI.GOV, Novo Holdings, and ArcTern Ventures.